July 30, 2014 1:47 PM ET

Biotechnology

Company Overview of JADO Technologies GmbH

Company Overview

JADO Technologies GmbH develops raft intervention therapeutics. It focuses on the drug development for mast cell derived allergic diseases, such as atopic dermatitis and asthma; and infectious diseases, including influenza, HIV, and tuberculosis. Its products include TF002, an allergy therapeutic formulation of miltefosine for the treatment of cutaneous mastocytosis and atopic dermatitis; Disrafters that are the modulators and small molecule inhibitors of pathogenic rafts to modulate intermolecular interactions integrating raft lipids and proteins; and Raftophiles, which are molecular delivery vehicles to position the drug at its cell membrane site of action. The company’s products also incl...

Tatzberg 47-51

Dresden,  01307

Germany

Founded in 2001

Phone:

49 351 796 3800

Fax:

49 351 796 3810

Key Executives for JADO Technologies GmbH

Founder and Scientific Advisor
Founder and Scientific Advisor
Founder and Scientific Advisor
Founder and Scientific Advisor
Co-Founder
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
CellMed AG Europe
Virofem Diagnostica GmbH Europe
Eckert & Ziegler EURO PET Koln-Bonn Europe
SpectraMab GmbH Europe
Amgen GmbH Europe

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JADO Technologies GmbH, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.